Ketamine controls prolonged status epilepticus

被引:140
作者
Borris, DJ [1 ]
Bertram, EH [1 ]
Kapur, J [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22903 USA
关键词
phenobarbital; ketamine; refractory seizure;
D O I
10.1016/S0920-1211(00)00175-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
New treatments are needed to control prolonged status epilepticus given the high failure rate of current therapies. In an animal model of status epilepticus based on electrical stimulation of the hippocampus, rats demonstrate at least 5 five-hours of seizure activity following stimulation. Phenobarbital (70 mg/kg) administered 15 min after stimulation effectively controlled seizures in 66% of animals (n = 6). When phenobarbital (70 mg/kg) was administered 60 min after stimulation, seizures were controlled in 25% of animals (n=4). Ketamine (100 mg/kg) administered 15 min after stimulation did not control seizures in any animal (n = 4). But when ketamine was administered one hour after stimulation it effectively controlled seizures in all animals (n = 4). Increasing doses of ketamine were administered 60 min after stimulation to generate a dose-response curve. The ketamine dose response (fraction of seizure free rats) data were fit to a sigmoid curve to derive an ED50 of 58 mg/kg. These findings suggest that prolonged status epilepticus becomes refractory to phenobarbital but can be effectively controlled by ketamine. For patients experiencing prolonged status epilepticus that is refractory to phenobarbital, ketamine may be an alternative to general anesthesia. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 25 条
[1]   NMDA RECEPTOR ANTAGONISTS AND LIMBIC STATUS EPILEPTICUS - A COMPARISON WITH STANDARD ANTICONVULSANTS [J].
BERTRAM, EH ;
LOTHMAN, EW .
EPILEPSY RESEARCH, 1990, 5 (03) :177-184
[2]   KETAMINE, PHENCYCLIDINE, AND MK-801 PROTECT AGAINST KAINIC ACID-INDUCED SEIZURE-RELATED BRAIN-DAMAGE [J].
CLIFFORD, DB ;
OLNEY, JW ;
BENZ, AM ;
FULLER, TA ;
ZORUMSKI, CF .
EPILEPSIA, 1990, 31 (04) :382-390
[3]   HIPPOCAMPAL PYRAMIDAL CELL LOSS IN HUMAN STATUS EPILEPTICUS [J].
DEGIORGIO, CM ;
TOMIYASU, U ;
GOTT, PS ;
TREIMAN, DM .
EPILEPSIA, 1992, 33 (01) :23-27
[4]  
DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316
[5]   POTENTIATION OF KAINIC ACID EPILEPTOGENICITY AND SPARING FROM NEURONAL DAMAGE BY AN NMDA RECEPTOR ANTAGONIST [J].
FARIELLO, RG ;
GOLDEN, GT ;
SMITH, GG ;
REYES, PF .
EPILEPSY RESEARCH, 1989, 3 (03) :206-213
[6]   THE COMPETITIVE NMDA RECEPTOR ANTAGONIST CGP-40116 PROTECTS AGAINST STATUS EPILEPTICUS-INDUCED NEURONAL DAMAGE [J].
FUJIKAWA, DG ;
DANIELS, AH ;
KIM, JS .
EPILEPSY RESEARCH, 1994, 17 (03) :207-219
[7]  
Kapur J, 1999, Curr Opin Neurol, V12, P191, DOI 10.1097/00019052-199904000-00010
[8]   Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons [J].
Kapur, J ;
Coulter, DA .
ANNALS OF NEUROLOGY, 1995, 38 (06) :893-900
[9]   Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABA(A) receptors [J].
Kapur, J ;
Macdonald, RL .
JOURNAL OF NEUROSCIENCE, 1997, 17 (19) :7532-7540
[10]   SELF-SUSTAINING LIMBIC STATUS EPILEPTICUS INDUCED BY CONTINUOUS HIPPOCAMPAL-STIMULATION - ELECTROGRAPHIC AND BEHAVIORAL-CHARACTERISTICS [J].
LOTHMAN, EW ;
BERTRAM, EH ;
BEKENSTEIN, JW ;
PERLIN, JB .
EPILEPSY RESEARCH, 1989, 3 (02) :107-119